Medy-Tox Inc. (KOSDAQ:086900)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotechnology	247.29B	228.62B	221.12B	195.10B	184.87B
Biotechnology Growth	8.17%	3.39%	13.34%	5.53%	31.27%
Total	247.29B	228.62B	221.12B	195.10B	184.87B
Total Growth	8.17%	3.39%	13.34%	5.53%	31.27%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea	90.72B	84.21B	79.82B	66.70B	59.72B
South Korea Growth	7.73%	5.50%	19.66%	11.70%	34.92%
Foreign Country	152.57B	140.56B	-	-	-
Foreign Country Growth	8.54%	-	-	-	-
Asia (Excl. South Korea)	-	-	73.71B	69.18B	49.78B
Asia (Excl. South Korea) Growth	-	-	6.56%	38.96%	-28.32%
Europe	-	-	6.56B	6.55B	4.00B
Europe Growth	-	-	0.15%	63.91%	72.88%
Middle East	-	-	8.54B	4.93B	3.71B
Middle East Growth	-	-	73.19%	32.88%	-11.54%
America	-	-	48.30B	43.63B	64.52B
America Growth	-	-	10.69%	-32.38%	218.59%
Other	-	-	226.72M	465.97M	-
Other Growth	-	-	-51.35%	-	-
Oceania	-	-	-	-	132.85M
Oceania Growth	-	-	-	-	0.18%
Africa	-	-	-	-	207.54M
Africa Growth	-	-	-	-	-6.82%
Total	243.29B	224.77B	217.16B	191.46B	182.07B
Total Growth	8.24%	3.51%	13.42%	5.16%	29.29%

Source: S&P Global Market Intelligence.